Arsenic trioxide (As 2 O 3 ) has been verified as a breakthrough in the management of acute promyelocytic leukemia in recent decades. However, cardiotoxicity, especially long QT syndrome (LQTS) has become the most important issue during As 2 O 3 treatment. The characterized mechanisms behind this adverse effect are inhibition of cardiac hERG channel trafficking and increase of cardiac calcium currents. In our study, we found a new pathway underlying As 2 O 3 -induced cardiotoxicity that As 2 O 3 accelerates lysosomal degradation of hERG on plasma membrane after using brefeldin A (BFA) to block protein trafficking. Then we explored pharmacological rescue strategies on As 2 O 3 -induced LQTS, and found that 4 therapeutic agents exert rescue efficacy via 3 different pathways: fexofenadine and astemizole facilitate hERG trafficking via promotion of channel-chaperone formation after As 2 O 3 incubation; ranolazine slows hERG degradation in the presence of As 2 O 3 ; and resveratrol shows significant attenuation on calcium current increase triggered by As 2 O 3 . Moreover, we used humaninduced pluripotent stem cell derived cardiomyocytes (hiPS-CMs) to evaluate the rescue effects of the above agents on As 2 O 3 -induced prolongation of action potential duration (APD) and demonstrated that fexofenadine and resveratrol significantly ameliorate the prolonged APD. These observations suggested that pharmacological chaperone like fexofenadine and resveratrol might have the potential to protect against the cardiotoxicity of As 2 O 3 .
Arsenic containing compounds have been used as medicine for more than 2000 years to treat diverse diseases including cancer, syphilis, and malaria (Antman, 2001; Waxman and Anderson, 2001; Zhou, 2012) . During the late 19th century and early 20th century, potassium arsenite was introduced for anti-leukemia therapy (Antman, 2001) . Only until recent decades was it used worldwide after Chinese physician Ting-Dong Zhang observed promising effect of arsenic trioxide (As 2 O 3 ) on acute promyelocytic leukemia (APL) patients. (Chen and Chen, 2017; Soignet et al., 2001; Zhang, 1984; Zhang et al., 2001) . Along with APL, this agent is also approved can treat primary hepatic carcinoma (He et al., 2016) and multiple myeloma (He et al., 2014) . However, the clinical application of As 2 O 3 is burdened by its toxicity, especially cardiac toxicity. QT interval prolongation, torsade de pointes (TdP) and sudden cardiac death have been reported (Naito et al., 2006; Ohnishi et al., 2000; Westervelt et al., 2001) .
In clinic, the emergence of QT prolongation and TdP during drug therapy signifies acquired long QT syndrome (acLQTS) which is induced by multiple mechanisms. The hallmark mechanism of acLQTS is inhibition of hERG (human ether-a-go-gorelated gene) potassium channel (include acute blockage and decrease of channel expression on cell surface) which is crucial for phrase 3 repolarization of cardiac action potential. Various different kinds of medications have been implicated with QT prolongation by targeting hERG channel. In addition, increases of inward calcium currents during the plateau phase of action potential would as well lead to significant QT prolongation (Splawski et al., 2005) . For As 2 O 3 caused LQTS, 2 different mechanisms have been reported: (1) increase of calcium currents (I Ca ), and (2) inhibition of hERG channels (Ficker et al., 2004) . The expression of hERG channels is controlled by anterograde trafficking of immature channels to, and retrograde degradation of mature channels from the plasma membrane. Previous works demonstrated that As 2 O 3 interferes with hERG forward trafficking by inhibition of hERG-chaperone complexes (Ficker et al., 2004; Zhao et al., 2014) . However, whether As 2 O 3 affects channel degradation has not been addressed. Therefore, we focused on hERG degradation after blocking its ER-to-Golgi transport, revealing a new pathway of hERG expression disruption by As 2 O 3 .
In another respect, considering that cardiotoxocity is the most adverse reaction during As 2 O 3 administration, it is important to search and develop useful prevention and treatment methods upon it. In the past decades, corrections on LQT2 (hERG gene associated congenital LQTS) mutations have been well studied (Smith et al., 2016; Vandenberg et al., 2012) . A series of studies showed that many phenotypes of different LQT2 mutants undergo correction by low temperature, small molecules (such as glycerol and DMSO) and/or many hERG blockers (including E-4031, astemizole, cisapride, etc). However, rescue strategies focus on drug-induced LQTS were rarely reported. Previous researchs found that fexofenadine, astemizole and ranolazine can effectively correct mutant hERG trafficking defect in vitro (Ficker et al., 2002; Rajamani et al., 2002; Smith et al., 2013) . On the other hand, resveratrol has been identified can shorten action potential duration (APD) through inhibition of L-type calcium currents (Zhang et al., 2006) . Thus, in our present research we explore the potential rescue effects and mechanisms of the 4 candidate drugs based on mechanisms underlying As 2 O 3 -induced QT prolongation. Moreover, we use human induced pluripotent stem cell derived cardiomyocytes (hiPS-CMs) model to evaluate their rescue efficacy. hiPS CMs are generated via cardiomyogenic differentiation of human induced pluripotent stem cells (hiPSCs). They display parallel ionic currents characteristics and stable contractile characteristics of adult human cardiomyocytes (Mehta et al., 2011; Puppala et al., 2013) , which make them successfully being used in disease modeling of LQTS and drug screening . Thus, our study will provide basis and information for the clinical application of As 2 O 3 and preclinical research of drug development.
MATERIALS AND METHODS
Cell culture. hERG-HEK293 cells, provided by Professor Zhiguo Wang from Harbin Medical University, were cultured in Dulbecco's Modified Eagle's Medium (DMEM; Hyclone, USA) supplemented with 10% fetal bovine serum (FBS, Bioind, Israel) and 400 lgÁml À1 gentamycin (G418, Invitrogen, USA).
Neonatal rat ventricular myocytes (NRVMs) were isolated from dissected hearts of 1-2-day-old neonatal Sprague-Dawley rats (The Experimental Animal Center of The Second Affiliated Hospital of Harbin Medical University, China) described previously in Yan et al. (2015) . The cells were incubated in DMEM with 10% FBS.
hiPS-CMs were obtained from CellapyBio (Beijing, China). Cells were cultured in Cardiomyocytes Maintenance Medium (CellapyBio). For electrophysiological recordings, 10 000-15 000 cardiomyocytes were digested and then plated on glass coverslips which were pre-coated with 500 ml of a 1:100 diluted matrigel solution (BD Biosciences, USA) overnight in 24-well plate. Cell culture medium was refreshed every 2 days.
All cells were incubated in an atmosphere of 5% CO 2 at 37 C.
Western blot analysis. Whole-cell protein lysates from hERG-HEK293 cells were separated by 8% SDS-PAGE, electroblotted to PVDF membranes, and blocked for 2 h using 5% non-fat milk. Subsequently, blocked membranes were probed with primary antibodies overnight. Immunoblotted membranes were then incubated with corresponding secondary antibodies for 1 h. The protein bands were detected by the Odyssey instrument (Gene Corporation, USA). Image studio software was used for data acquisition.
Immunoprecipitation. A total of 1.0 mg whole-cell proteins from hERG-HEK293 cells in 0.1 ml Radio Immunoprecipitation Assay (RIPA) lysis buffer were incubated with 2.0 lg appropriate primary antibody. The mixture was placed on a 360 shaker overnight at 4 C, and then added with 30 ll protein A/G PLUS agarose beads (Santa Cruz) overnight too. The beads were washed 3 times with 500 ll ice-cold TBST buffer. Finally, 150 ll 1 Â loading buffer was added to the precipitations, and then boiled for 8 min and centrifuged at 1500 rpm for 5 min. The supernatants were sucked up for Western blot analysis.
Immunofluorescence. hERG-HEK293 cells were seeded on polylysine-coated coverslips with proper density before 8 hexposure to control conditions or drug treatment. The fluorescence signal was measured as previous described in Zhang et al. (2014) . Briefly, cells were fixed in staining fix solution (Beyotime, China) for 15 min, permeabilized with 0.4% Triton-100 (Beyotime) and blocked with 10% goat serum (Boster, China) for 1 h, then incubated with antihERG antibodies overnight. The next day cells were incubated with Rabbit Alexa Fluor 488 (Molecular Probes) in dark for 2 h. Finally, cells on coverslips were imaged with a fluorescence microscope.
Measurement of calcium concentration ([Ca
] i ). NRVMs cultured on 24-well plate were treated with As 2 O 3 or resveratrol for 24 h after deprivation of serum for 12 h. Intracellular [Ca 2þ ] i was measured by Confocal Laser Scanning Microscope (Olympus, Japan). The procedure was described as previously (Zhao et al., 2013) . NRVCs were loaded with Fluo-3/AM (Invitrogen) for 40 min before detection. The sample was scanned every 3 s for about 300 s in normal Ca 2þ -containing Tyrode's solution. KCl (30 mM) was added at 60 s. The relative magnitude of fluorescent signals was calculated as FI/F0, where F0 represents the basal level of fluorescence and FI the value was after drug treatment.
Patch clamp techniques. Currents and APD were measured using whole-cell patch clamp technique under voltage-clamp and current-clamp mode, respectively. The procedures were described as previously in Yan et al. (2015) and Zhao et al. (2013 -containing Tyrode's solution. The pipette solution for APD recorded in NRVMs contained 20 mM KCl, 110 mM KOH, 1 mM MgCl 2 Á6H 2 O, 10 mM HEPES, 5 mM Na 2 -ATP, 5 mM EGTA, and 110 mM aspartate (pH 7.3 with KOH). The pipette solution for APD recorded in hiPSCMs contained 120 mM KCl, 1 mM MgCl 2 Á6H 2 O, 10 mM HEPES, 3 mM Mg-ATP and 10 mM EGTA (pH 7.3 with KOH).
Agents and antibodies. As 2 O 3 (provided by Pharmaceutical Co. Limited of Harbin Medical University) was dissolved in normal saline; brefeldin A (BFA) (Beyotime) was dissolved in ethanol; fexofenadine (Sigma, California, USA) and astemizole (Sigma) were dissolved in DMSO; ranolazine (Sigma) was dissolved in double distilled water; resveratrol (Aladdin Industrial Corporation, China) was dissolved in ethanol. Drug stock solutions were diluted in DMEM before use. In rescue experiments, pharmacological compounds were added 1 h before As 2 O 3 .
Rabbit anti-hERG antibodies were purchased from Santa Cruz. Mouse antiHsp70 and antiHsp90 antibodies were purchased from Abcam. Rabbit antiRab11 antibodies were purchased from Cell Signaling Technology. Rabbit anti-IgG antibodies were purchased from Elabscience Biotechnology (Wuhan, China). Mouse anti-b actin antibodies were purchased from ZSBG-Bio (Beijing, China).
Statistical analysis. Data are presented as means 6 SEM. ANOVA and Student's t test were used to identify the differences between the means. p values < .05 were considered statistically significant. GraphPad Prism 5.0 and Origin 9.0 were used for statistical analysis and graphing.
RESULTS

As 2 O 3 Accelerates the Degradation of hERG Channel on Cell Surface
We first study the effect of As 2 O 3 on hERG degradation in which BFA (10 mM) was used to block protein trafficking from ER to Golgi. Figures 1A and B showed time-dependent degradation of the 155-kDa hERG protein in both control and As 2 O 3 -treated cells after BFA treatments. When compared with control group, As 2 O 3 treatment markedly accelerated the degradation rate of hERG, reflected in that the 155-kDa hERG band intensity decreased by 44.5% 6 5.8% in control cells, whereas it decreased by 68.4% 6 1.8% in As 2 O 3 -treated cells after an 8 h BFAincubation. Consistent with these findings, immunofluoresence results ( Figure 1C ) showed that following BFA incubation, As 2 O 3 significantly reduced mature hERG protein (green on cell membrane). In summary, As 2 O 3 accelerates the degradation of mature hERG channels.
Next, we determine whether the improved degradation of hERG is mediated by ubiquitination. After immunoprecipitation with anti-hERG or anti-ubiquitin antibody, immunoprecipitates were blotted with either anti-ubiquitin or anti-hERG antibody. On Western blots we did not detect distinct changes in hERG ubiquitination after As 2 O 3 treatment (Figs. 1D and E) .
To further explore the intrinsic mechanism of hERG degradation by As 2 O 3 , we detected the expression of caveolin-1 (Cav-1), an integral membrane protein co-localized with hERG on cell surface. And Cav-1 has been reported to involve in druginduced reduction of hERG plasma-membrane expression (Guo et al., 2011 , Yan et al., 2015 . In our research, As 2 O 3 decreased Cav-1 level in a concentration-dependent manner ( Figure 1F ), suggesting that Cav-1 accounted for As 2 O 3 -promoted hERG degradation.
To investigate the fate of disordered hERG proteins, proteasome inhibitor MG132 and lysosome inhibitor bafilomycin were used. Figures 1G-I show that 10 nM bafilomycin restored the decreased 155-kDa hERG with a rescue ratio at 43.96%, which suggests that lysosomes mediate 155-kDa hERG degradation. Impaired 135-kDa hERG were increased by 3 lM MG132 and 10 nM bafilomycin with rescue ratios at 44.35% and 53.58%, which suggests that both proteasomes and lysosomes mediate 135-kDa hERG degradation.
Pharmacological Rescue of As 2 O 3 -Induced hERG Defect by Fexofenadine
Fexofenadine, an antihistamine of the second generation, has been reported can rescue the trafficking-defective hERG mutations of N470D and G601S without block (Rajamani et al., 2002) . To investigate whether it could rescue hERG inhibition induced by As 2 O 3 , we detect the expression of hERG proteins using Western blot analysis. hERG-HEK293 cells were incubated with 3 lM As 2 O 3 , followed by different concentrations of fexofenadine (0.1, 1, and 5 lM) for 24 h. As shown in Figure 2A , 3 mM As 2 O 3 decreased the expression of hERG protein on cell surface, which is consistent with the previous researches (Ficker et al., 2004) . And application of 1 or 5 mM fexofenadine successfully recovered the mature hERG reduction. The rescue ratios were 32.56% (1 mM) and 29.69% (5 mM), respectively. To further explore whether the recovered hERG channels were functional, we analyzed hERG currents recorded from hERG-HEK293 cells, which were incubated with As 2 O 3 (3 mM) and fexofenadine (1 mM) for 24 h. Considering that fexofenadine is a weak blocker of hERG channels, the drug was washed out for 2 h before recording. In Figures 2B and C, fexofenadine (1 mM) presents rescue effect on hERG currents inhibited by As 2 O 3 (3 mM). The rescue ratio was 25.49%.
It is well known that Hsp70 and Hsp90 are 2 cytosolic chaperones crucial for the maturation of cardiac hERG potassium channel (Ficker et al., 2003) . Both of them interact with the unmature form of hERG (135-kDa) present in the endoplasmic reticulum. A study has reported that As 2 O 3 impeded the formation of hERG-Hsp70 and hERG-Hsp90 complexes, thus restricted the trafficking of hERG from ER to cell surface (Ficker et al., 2004) . To explore the mechanisms of fexofenadine in reversing As 2 O 3 -induced hERG defect, we studied its effect on hERGHsp70 and hERG-Hsp90 complexes using co-immunoprecipitation experiments after As 2 O 3 treatment. From Figures 2D and E, we found that the amount of hERG protein interacting with Hsp70 or Hsp90 was decreased in the presence of 3 mM As 2 O 3 . However, application of 1 mM fexofenadine increased the interactions between hERG and the chaperones when coincubation with 3 mM As 2 O 3 .
These data demonstrated that fexofenadine produced functional rescue on As 2 O 3 -induced hERG defect through facilitating channel/chaperone interactions.
Pharmacological Rescue of As 2 O 3 -Induced hERG Defect by Astemizole Astemizole, another antihistamine of the second generation, also has been reported can rescue the trafficking-defective hERG mutations of N470D and G601S (Ficker et al., 2002; Zhou et al., 1999) . We tested its effect on As 2 O 3 -induced hERG defect as well. Figure 3A showed hERG expression immunoblotted from cells incubated with 3 lM As 2 O 3 and 0.1, 1, or 5 lM astemizole. This agent resulted in concentration-dependent rescue on impaired hERG protein. The rescue ratios were 31.25% (1 mM) and 44.36% (5 mM). However, in electrophysiological experiments it failed to recover hERG currents although the drug was washed out for 2 h before recording (Figs. 3B and C) . Likewise, we performed co-immunoprecipitation analysis to explore the mechanism of astemizole in reversing hERG protein reduction. From Figures 3D and E, we found that application of 5 mM astemizole increased the interactions between hERG and the chaperones when co-incubation with 3 mM As 2 O 3 . Hence, our analysis suggests that astemizole generates nonfunctional correction on As 2 O 3 -induced hERG defect.
Pharmacological Rescue of As 2 O 3 -Induced hERG Defect by Ranolazine Ranolazine, an agent used to treat angina, has been reported to correct trafficking of G601S-hERG stored in ER (Smith et al., 2013) . To test whether it also could produce a rescue effect, we measured the protein expression after combination of As 2 O 3 and ranolazine. Results showed that low concentration of ranolazine corrects hERG expression ( Figure 4A ) with rescue ratios of antibody and immunoblotted using anti-hERG antibody (E). n ¼ 3. (F) As2O3 caused a concentration-dependent reduction of Cav-1 in hERG-HEK293 cells for 24 h-incubation (n ¼ 4). Impared hERG proteins are degraded in both lysosome and proteasome. hERG expression was detected by Western blot after 24 h-incubation (G). MG132 and bafilomycin increased the reduced 135-kDa hERG (H); bafilomycin restored the reduced 155-kDa hERG (I) (n ¼ 5). *p < .05 versus control and #p < .05 versus As 2 O 3 .
26.57% (5 mM) and 29.50% (10 mM). While high concentration of ranolazine not only has no rescue effect, but further decreases mature hERG proteins ( Figure 4B ). Next, we recorded current amplitude of hERG channel after combination of 5 mM ranolazine and 3 mM As 2 O 3 for 24 h. As might be anticipated, ranolazine reversed current reduction by As 2 O 3 treatment (Figs. 4C and D). The rescue ratio was 18.75%.
And naturally, we deem that ranolazine promotes hERG chaperone interactions and then correct channel trafficking. Thus, we conducted co-immunoprecipitation analysis. Out of the blue, the disordered hERG-Hsp70 and hERG-Hsp70 complexes were not altered by ranolazine (Figs. 4E and F) . To interrogate whether improvement of trafficking contributes to the rescue effect of ranolazine, we monitored hERG expression in the conditions that ER-to-Golgi transport was blocked by BFA. Surprisingly, ranolazine still reversed hERG reduction after 8 h-BFA incubation ( Figure 4G ). The rescue ratio was 28.47%. These results imply that ranolazine ameliorates As 2 O 3 -induecd acceleration of hERG degradation.
Pharmacological Rescue of As 2 O 3 -Induced I Ca,L Increase by Resveratrol Resveratrol, a naturally antioxidant agent, exerts considerable antiarrhythmic efficacy in recent years. It has been demonstrated to produce a shortening effect on APD through inhibition of I Ca,L . To test whether resveratrol could relieve As 2 O 3 -induced I Ca,L increase, we recorded calcium current in NRVMs. As described in Figure 5B , the amplitude of I Ca,L was increased by 95.46% in As 2 O 3 -treated ventricular cardiomyocytes at 0 mV. Application of 10 mM resveratrol recovered this effect in the presence of 3 mM As 2 O 3 . The cardiac calcium channels play a key role in managing the intracellular calcium concentration ([Ca 2þ ] i ) and [Ca 2þ ] i increase in the cardiac tissue has been associated with a variety of abnormalities, including arrhythmias. Hence, we further measured [Ca 2þ ] i using confocal laser scanning microscope. Our results indicated that [Ca 2þ ] i was markedly greater in As 2 O 3 -treated group than that in the control group, and resveratrol significantly inhibited As 2 O 3 -induced [Ca 2þ ] i accumulation (Figs. 5C-E).
Effects of Fexofenadine and Ranolazine on the APD Prolonged by As 2 O 3 in NRVMs
To test whether our results obtained in heterologous expression system could be extended to cardiomyocytes, we studied the effects of these rescuable drugs on As 2 O 3 -prolonged APD in NRVMs. Previous studies reported that resveratrol shortened APD prolonged by As 2 O 3 in guinea pig ventricular cardiomyocytes (Zhao et al., 2014) and ameliorated mouse QT interval prolongation induced by As 2 O 3 (Zhao et al., 2008) . And astemizole failed to rescue hERG currents in our study. Thus, we used fexofenadine and ranolazine to perform this experiment. Fexofenadine promoted the formation of hERG-Hsp70 and hERG-Hsp90 complexes in the presence of As2O3. hERG image densities in immunoprecipitations with antihERG antibody were used as measure of total hERG protein (n ¼ 5). *p < .05 versus control and #p < .05 versus As 2 O 3 .
To detect the effects of fexofenadine and ranolazine on the prolongation of cardiac action potentials after As 2 O 3 administration, 1 mM fexofenadine or 5 mM ranolazine was added to myocytes in the presence of 3 mM As 2 O 3 . Results indicated that the prolonged APD were significantly shortened (APD 50 shortened to 144.95 6 8.22 and 157.63 6 4.97 ms, respectively; APD 90 shortened to 233.30 6 18.75 and 267.10 6 11.33 ms, respectively). These data demonstrated that both fexofenadine and ranolazine successfully ameliorated APD prolongation induced by As 2 O 3 .
Effects of Fexofenadine, Ranolazine and Resveratrol on the APD Prolonged by As 2 O 3 in hiPS-CMs
Here, we cultured hiPS-CM to measure the APs for further validating the reverse function of those drugs. As expected, application of 3 mM As 2 O 3 obviously prolonged APD of the myocytes (Figure 7 Taken together, these data illustrated that fexofenadine and resveratrol alleviated As 2 O 3 -triggered APD prolongation in hiPSCMs, while ranolazine failed to reverse.
DISCUSSION
In this study, first we revealed a novel pathway underlying the cardiotoxicity of As 2 O 3 that it promoted lysosomal-degradation of hERG channels on plasma membrane. Second, we demonstrated the rescue effects of 4 therapeutic drugs through 3 different pathways on the proarrhythmia of As 2 O 3 based on its multiple action mechanisms, and identified that fexofenadine and resveratrol produced significantly relief on As 2 O 3 -induced APD prolongation of hiPS-CMs. hERG potassium channel is crucial for phrase 3 repolarization of cardiac action potential. A large variety of medications trigger LQTS by targeting hERG channels. Pentamidine produces QT prolongation and torsades de pointes in patients by inhibition of hERG trafficking (Kuryshev et al., 2005) . Probucol accelerated hERG protein degradation on cell membrane (Guo et al., 2011) . hERG channels are synthesized in 2 forms: an immature core-glycosylated protein of 135-kDa that is localized to the ER, and an mature fully glycosylated protein of 155-kDa which is transported to the cell surface. One of the mechanisms underlying As 2 O 3 -induced LQTS is disruption of hERG trafficking to plasma membrane. However, whether As 2 O 3 affects hERG channel at cell membrane level remains unknown. The present result showed that As 2 O 3 increases surface hERG degradation, which is not mediated by channel ubiquitination (Figure 1 ). And As 2 O 3 decreased the expression of Cav-1 [an integral membrane protein has been reported to interact with hERG channel and regulate hERG expression (Lin et al., 2008) ], which suggests Cav-1 involves in As 2 O 3 -lead degradation of hERG in plasma membrane. The subsequent test shows that bafilomycin recovered 155-kDa hERG, implying that As 2 O 3 increases lysosomemediated mature hERG degradation. Meanwhile, MG132 and bafilomycin increased 135-kDa hERG, suggesting that misprocessed hERG caused by As 2 O 3 undergoes both proteasome-and lysosome-mediated degradation.
Antihistamine fexofenadine and astemizole have been shown to rescue trafficking-deficient LQT2 mutations (Rajamani et al., 2002; Zhou et al., 1999) . In our research, both the 2 agents produced effective rescue on hERG inhibition in the presence of As 2 O 3 by facilitating channel-chaperone formation (Figs. 2 and 3) . But interestingly, compared with the immunoblot analysis, functional study on rescued hERG channel using whole-cell patch clamp presented controversial results: astemizole showed significant rescue on hERG proteins but not on currents. This is probably a consequence of that astemizole is a potent hERG blocker and a 2 h-washout is not enough to dissotiate drug-channel complex. There also have another possible reason that hERG proteins transported to plasma membrane are nonconducting. If this assumption is true, we interpret this to mean that the way to facilitate hERG trafficking of fexofenadine and astemizole differ from each other. We also monitored the rescue effects of the 2 drugs after inhibiting protein trafficking using BFA and found there was no reversal effect on hERG Average values were described as mean 6 SEM, n indicates the number of cardiomyocytes. *p < .05 versus control and #p < .05 versus As2O3. expression, suggesting they don't affect As 2 O 3 -promoted hERG degradation (data not shown). Ranolazine, an agent used to treat angina, has previously been found to correct channel trafficking of G601S-hERG mutation (Smith et al., 2013) . In our work, it also exerts rescue efficacy on As 2 O 3 -induced hERG defect (Figure 4) , which is similar to effect of fexofenadine and astemizole. But the mechanism underlying this rescue is not facilitation of channel-chaperone interaction. To exclude the possibility that ranolazine reverses As 2 O 3 -induced hERG defect via other mechanisms than promoting channel trafficking, we monitor the rescue effect after suppressing protein trafficking process using BFA. Surprisingly, ranolazine still gave a significant rescue in this trial ( Figure 4G ) and there was no discrepancy between the rescue ratios measured with or without BFA treatment, indicating ranolazine slowed As 2 O 3 -stimulated hERG degradation. Noteworthily, ranolazine at the concentration of correcting misprocessed G601S-hERG (50 lM, much higher than its therapeutic concentration) failed to rescue As 2 O 3 -induced hERG trafficking inhibition. It provides an evidence that ranolazine rescues mutant-or drug-leaded hERG trafficking defect in 2 different ways, which are needed further research.
Another identified mechanism behind As 2 O 3 -induced abnormalities of cardiac electrophysiology is increase of calcium currents (Chen et al., 2010; Ficker et al., 2004) , which plays a key role in maintaining the normal APD of cardiomyocytes as well as [Ca 2þ ] i . Resveratrol is a natural polyphenol derived from several plants include peanuts, grapes and mulberries. Previous evidences showed that it possesses protective effects on cardiovascular system (Das and Maulik, 2006; Dudka et al., 2012; Sulaiman et al., 2010) . It was also reported that resveratrol decreases calcium currents of guinea pig myocytes (Zhang et al., 2006) , and relieves As 2 O 3 -generated [Ca 2þ ] i acceleration and reactive oxygen species (ROS) overproduction (Zhao et al., 2008) . In present research, it produced distinct inhibition on As 2 O 3 -amplified calcium currents (Figs. 5A and B). It also attenuated As 2 O 3 -triggered intracellular calcium overload (Figs. 5C-E), whereas fexofenadine, astemizole and ranolazine did not exert significant mitigative effect (data not shown). On the other hand, we have previously shown that resveratrol also attenuated As 2 O 3 -induced hERG defect via relief of endoplasmic reticulum stress (ERS) and facilitation of channel-chaperone interaction (Zhao et al., 2014) . This combined action of resveratrol targeting hERG channel and calcium channel may interpret its powerful rescue efficacy on As 2 O 3 -induced APD prolongation of hiPS-CMs ( Figure 7 and Table 2 ). In addition, previous studies revealed that ROS negatively modulates hERG channels Zhang et al., 2003) and can activate the occurrence of ERS Zhou et al., 2016) . Thus, we speculate that ROS-ERS cascade reaction plays an important regulatory role and suppression of overproduction of ROS contributes to the rescue effect of resveratrol in As 2 O 3 -induced LQTS. Recent progress in hiPSCs oriented differentiation provides a large quantity of myocytes for the research of cardiac functions, cardiac diseases and drug development (Davis et al., 2011; Zhang et al., 2009 ). hiPS-CMs share similar features with adult human cardiomyocytes in many aspects (Blazeski et al., 2012) . Owing to the convenience and accuracy, in vitro experiment on hiPS-CMs has been accepted as a new technology likely to revolutionize cardiac safety and drug development (Paci et al., 2015) , and it will reduce or replace in vivo and ex vivo animal experiments. In our study, we explore the rescue potential of candidates on As 2 O 3 -induced APD prolongation in NRVMs and hiPS-CMs. We demonstrated that fexofenadine and ranolazine ameliorated APD prolongation of NRVMs ( Figure 6 and Table 1 ). Intriguingly, instead of modest shortening, ranolazine prolonged the destroyed APD by As 2 O 3 measured in hiPS-CMs ( Figure 7 and Table 2 ). The results may be attributable to (1) species difference in the expression profiles of cardiac ion channel; and (2) complex multichannel inhibition produced by ranolazine. Resveratrol also exert significant reversal on the prolonged APD elicited from hiPS-CMs ( Figure 7 and Table 2 ).
In conclusion, pharmacological rescue based on various action mechanisms occurs on As 2 O 3 -induced abnormal myocardial electrophysiology. We propose that pharmacological chaperone activity of compounds like fexofenadine and resveratrol might have therapeutic potential to attenuate the cardiotoxicity of As 2 O 3 .
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